Global  Video

“The world's speediest news portal”
One News Page
> >

U.S. FDA approves biosimilar version of cancer drug Avastin

Reuters Thursday, 14 September 2017
(Reuters) - The U.S. Food and Drug Administration said on Thursday it has approved Amgen Inc's biosimilar version of Roche Holding AG's cancer drug Avastin.
Share on
Share on
Post on 
Share by
Source: RTV6 The Indy Channel - < > Embed
News video: Drug tested to lessen chemo side effects at IU Health

▶ Drug tested to lessen chemo side effects at IU Health 01:39

With a $2.9 million grant, the IU Cancer Center has begun testing a new drug to lessen the side effects of chemotherapy. Doctors at the Simon Cancer Center are looking to develop the drug to help cancer patients.

Recent related news

FDA Accepts New Drug Application and Grants Priority Review for Ivosidenib in Relapsed or Refractory AML with an IDH1 Mutation

– PDUFA date set for August 21, 2018 –CAMBRIDGE, Mass., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of...
GlobeNewswire - Press ReleasesAlso reported by •Business Wire

Global Anticancer Drug Market- Providing Targeted Treatment Solutions to Cancer Patients Using Nano-Technology Enhancing the Way to Cure the Disease, Reach USD 145.2 Billion By 2023: Energias Market Research Pvt. Ltd.

NEW YORK, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Global Anticancer Drug market size is expected to reach *USD 145.2 Billion in 2023*, at a *CAGR of 6.7%* from 2017...
GlobeNewswire - Press Releases

You Might Like

Tweets about this

Other recent news in Health

Fathers may pass OVARIAN CANCER risk to daughtersTRANSGENDER woman breastfeeds baby in first recorded case, study says
McDonald's plays 'hide the cheeseburger' in new HAPPY MEAL health pushNokia starts review of DIGITAL HEALTH business, cuts jobs in Finland
Coping With Fear, Anxiety Over Parkland SCHOOL ShootingBorneo Has Lost 100,000 ORANGUTANS Since 1999
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2018 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+